Humana (HUM) Aktsia Kursus
Humana Kursus
Viimase 19 aasta jooksul kasvas Humana käive 9,9 % aastas ja jõudis 129,66 B USD-ni. Kasum aktsia kohta kasvas 6,7 % aastas viimase 19 aasta jooksul. Humana netomarginaal 0,9 % on langenud võrreldes 3,5 %-ga mõni aasta tagasi. Tänase hinna juures on dividenditootlus umbes 0,86 %. Väljamaksesuhe on umbes 36 % kasumist. Dividend kasvas 11,7 % aastas viimase 14 aasta jooksul. Humana 12 kuu konsensuse hinnasiht on 412,50 USD, umbes üle kurssi 0,2 %. 32 analüütikust 16 soovitab osta — üldine konsensus on Osta.
Humana aktsiahinnad
Hangi need andmed Eulerpool API kaudu
100 000 päringut/kuus tasuta · krediitkaarti pole
Humana ärimudel ja aktsia analüüs
Korduma kippuvad küsimused Humana aktsia kohta
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analüütikud määravad Humana aktsiale keskmiseks hinnasihi 416,78 USD (mediaan: 412,50 USD), mis on +0,5 % viimase hinna suhtes. Konsensus põhineb 32 analüütiku hinnangul.
32 analüütikut hindavad praegu Humana aktsiat: 16 soovitab osta, 15 hoida ja 1 müüa. 2026. aastaks ootavad analüütikud, et Humana teenib tulu 162,56 B USD ja kasumit aktsia kohta 9,14 USD.
Praeguse kursiga kaubeldakse Humana aktsiaga 369,54 EUR (411,87 USD) juures.
Humana aktsia (HUM) on noteeritud 7 börsil, sh: NYSE (HUM), London (0J6Z.L), SIX (Zürich) (HUM.SW), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
oodatav Humana käive on 162,56 B USD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.
oodatav Humana kasum on 1,10 B USD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.
Võrdlusarvud hinna ja kasumiga (P/E) Humana jaoks on praegu 45,08. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Humana aktsia väärtust.
Kursuse ja müügimahu suhe (P/S) Humana jaoks on praegu 0,30. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Humana aktsia jaoks.
Eulpooli kvaliteedinäitaja Humana jaoks on 5/10.
Humana ISIN on US4448591028. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.
Humana WKN on 856584. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.
Humana ticker on HUM. Ticker-sümbol kasutatakse Humana aktsiate kauplemiseks börsil.
Humana aktsia
Humana konkurendid
Humana Börsiticker
Humana FIGI
Kõik teised näitajad ja analüüsid Humana kohta sügavamalt
Meie Humana-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Humana. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: